Selected stock price target news of the day - May 19th, 2025

By: Matthew Otto

Celcuity Reports First Quarter 2025 Results and Updates on Clinical Pipeline Progress

Celcuity reported a net loss of $37 million for the first quarter ended March 31, 2025, or ($0.86) per share. This result was $0.14 below the analyst estimate of ($0.72) and compared to a loss of $21.6 million, or ($0.64) per share, in the first quarter of 2024. Operating expenses increased 60% year-over-year to $36.1 million. This includes $32.2 million in research and development costs and $3.9 million in general and administrative expenses. Cash used in operations was $35.9 million, up from $17.1 million in the same period last year.

As of March 31, 2025, Celcuity held $205.7 million in cash, cash equivalents, and short-term investments, which it expects will support clinical operations through 2026. R&D spending increased by $11.6 million, of which $5.9 million was attributed to employee and consulting expenses and $5.7 million to clinical trial-related activities.

The VIKTORIA-1 Phase 3 trial is evaluating gedatolisib in patients with HR+/HER2- advanced breast cancer. A condition diagnosed in approximately 300,000 women annually in the U.S. and EU combined. The VIKTORIA-2 Phase 3 trial is scheduled to begin dosing patients in the second quarter of 2025 and will include a safety run-in of 12 to 36 participants. Additionally, the CELC-G-201 study in metastatic castration-resistant prostate cancer, affecting over 80,000 men in the U.S., is expected to report Phase 1b safety data in late Q2 2025. A separate collaboration with Dana-Farber Cancer Institute and Massachusetts General Hospital will investigate gedatolisib in combination therapies for endometrial cancer, which sees approximately 60,000 new diagnoses annually in the U.S.

Analyst Maintains Rating and Target Following Results and Updates

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterated a Buy rating and a $27 price target.

Which Analyst has the best track record to show on CELC?

Analyst Alexander Nowak (CRAIG HALLUM) currently has the highest performing score on CELC with 3/5 (60%) price target fulfillment ratio. His price targets carry an average of $9.34 (52.89%) potential upside. Celcuity stock price reaches these price targets on average within 271 days.

Bit Digital Reports First Quarter 2025 Results with Shift Toward Cloud and Colocation Services

Bit Digital reported first quarter 2025 revenue of $25.1 million, a 17% decrease compared to $30.2 million in the same period last year and below the consensus estimate of $28.69 million. Reported a net loss of $0.32 per diluted share, compared to earnings of $0.43 per share in the prior-year quarter and below the analyst estimate of a $0.03 loss.

Bitcoin mining revenue declined 64% to $7.8 million from $21.9 million in Q1 2024. Cloud services revenue increased 84% to $14.8 million, up from $8.1 million. Colocation services, not present in the prior-year quarter, contributed $1.6 million. ETH staking revenue increased 72% year-over-year to $0.6 million.

As of March 31, 2025, digital asset mining accounted for 31% of total revenue, compared to 72% a year ago and 40% in the previous quarter. Bit Digital ended the quarter with $61.3 million in cash, cash equivalents, and restricted cash, and total liquidity of approximately $141.4 million, which includes USDC and digital assets.

Operationally, Bit Digital earned 83.3 bitcoins, down 80% from 417.1 bitcoins in Q1 2024. Earned 211 ETH during the quarter and reported holdings of 417.6 BTC and 24,434.2 ETH, valued at approximately $34.5 million and $44.5 million, respectively, as of March 31. The active bitcoin hash rate was 1.5 EH/s, down from 2.2 EH/s in Q1 2024, while the total deployed fleet reached 20,854 miners with a maximum potential hash rate of 2.4 EH/s. ETH actively staked a total of approximately 21,568.

Adjusted EBITDA was negative $44.5 million, compared to positive $58.5 million in the prior-year quarter. Reflecting a $49.2 million mark-to-market loss on digital assets versus a $45.7 million gain in Q1 2024. During the quarter, Bit Digital signed contracts totaling over 200 NVIDIA H200 GPUs, a five-year colocation agreement with Cerebras Systems for 5MW of capacity, and two new GPU service orders with Boosteroid totaling 701 servers. Subsequent to quarter-end, Bit Digital signed agreements for 616 additional H200 GPUs and entered into a definitive agreement to acquire a data center property in North Carolina.

Analyst Reiterates Rating and Target Despite Q1 Miss

HC Wainwright & Co. analyst Kevin Dede reiterated a Buy rating and a $7 price target.

Which Analyst has the best track record to show on BTBT?

Analyst Kevin Dede (HC WAINWRIGHT) currently has the highest performing score on BTBT with 7/14 (50%) price target fulfillment ratio. His price targets carry an average of $5.24 (297.73%) potential upside. Bit Digital stock price reaches these price targets on average within 127 days.

Endava Reports Q3 FY2025 Profit Growth Despite Revenue Miss and Lowers Outlook

Endava reported third quarter fiscal 2025 revenue of $260 million, an 11.7% increase year over year, though it came in below the consensus estimate of $266 million. Earnings per share for the quarter were $0.45, exceeding analyst expectations by $0.04. Profit before tax reached $18.1 million, compared to a loss of $0.7 million in the same period last year, while net profit totaled $14.5 million, reversing a net loss of $2.2 million a year earlier. Operating cash flow was $25 million, up from $4 million in Q3 FY2024.

For Q4 FY2025, Endava expects EPS between $0.29 and $0.32, well below the consensus of $0.6, and revenue in the range of $248 to $250 million, compared to analysts’ expectations of $359 million. For the full fiscal year, Endava now forecasts EPS between $1.47 and $1.50 and revenue between $1.028 and $1.031 billion. Both under the consensus estimates of $2.10 for EPS and $1.434 billion for revenue.

Analyst Downgrades Following Q3 Revenue Miss and Reduced Guidance

JP Morgan analyst Puneet Jain downgraded from Overweight to Neutral and announced an $18 price target.

Which Analyst has the best track record to show on DAVA?

Analyst Mayank Tandon (NEEDHAM) currently has the highest performing score on DAVA with 10/21 (47.62%) price target fulfillment ratio. His price targets carry an average of $3.22 (21.79%) potential upside. Endava stock price reaches these price targets on average within 93 days.